Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale CAMBRIDGE, England — EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 […]
Developing synthetic cells for a range of applications in diagnostics and therapeutics EMERYVILLE, Calif. — Slingshot Biosciences, a biotechnology company building the world’s first on-demand synthetic cell platform for customizing cell and cell line mimics, today announced the closing of $11 million in a Series A3 financing. The investment was co-led by ARCH Venture Partners and Northpond Ventures, […]
Funding received from the Bill & Melinda Gates Foundation for rapid deployment of novel detection reagents to support mass scale testing in low to middle-income countries Bedfordshire, UK: MIP Discovery, a leader in rationally designed detection reagents based on its proprietary nanoMIP™ technology, has today announced it has secured a significant grant of funds from the Bill […]
The successful development of the measurement technology specialist from Graz continues: On the one hand, new subsidiaries were founded in the Netherlands and in the Philippines, on the other hand, Anton Paar was also able to achieve a turnover of more than half a billion euros for the first time in the company’s history. With […]
New partnerships will drive the commercial expansion of InDevR’s game-changing solutions for vaccines and biotherapeutics Boulder, CO — InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant Capital has invested $4 million, and bioMérieux – a worldwide leader in in vitro diagnostics […]
LePure Biotech is a leading provider of high-quality and innovative single-use bioprocessing solutions in China Proceeds will be used to continue to accelerate product innovation and advance LePure Biotech’s go-to-market strategy SHANGHAI — Shanghai LePure Biotech Co., Ltd. (“LePure” or “LePure Biotech”) announced the completion of its Series C financing from a consortium of world-renowned investors […]
Positioned to Meet Growing Customer Demand for Accurate, Real-Time Emissions Data to Smooth the Global Energy Transition Combination Will Allow Spectaire to Pursue Significant Market Opportunity. The proposed business combination is expected to allow Spectaire to better fulfill growing demand for monitoring and measurement technology needed to meet emissions reduction commitments. Customers are able to save […]
OMRON Ventures joins existing investors abrdn, Environmental Technologies Fund and consortium led by Granpool Innovative Investments Scale-up focused on enabling novel, sustainable scientific innovations that harness the microbiome to solve for ‘One Health’ challenges, through development of AI-augmented knowledge discovery platform, e[datascientist]™ CAMBRIDGE, England — Today, Eagle Genomics, the pioneering TechBio platform business applying network science[1] to biology, disclosed […]
Making proteomics 100x more robust and 10x faster ODENSE, DENMARK – Evosep Aps – Evosep today announced that Novo Holdings A/S has become a minority shareholder in Evosep Aps with a US$ 40m investment to further Evosep’s technology and application portfolio for clinical proteomics. Evosep aims to improve quality of life and patient care by […]
The company is the first cloud infrastructure provider built specifically for the life sciences and manufacturing industries, integrating lab instruments, apps, files, and user-defined code into one harmonized data platform New capital will support the ongoing development of the company’s cloud-native data platform, cloud IDE, and self-service tooling PALO ALTO, Calif. — Ganymede Bio, the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
